United States
Alpha Genesis Inc., founded in 2003, stands at the forefront of the nonhuman primate research industry as a significant service provider under the banner "Full-Service Nonhuman Primate Research Solutions." As the largest organization of its kind in the United States, it offers a comprehensive suite of services crucial for advancing vaccine, gene therapy, and small-molecule research.
The company’s integrated capabilities from breeding and long-term primate care to GLP (Good Laboratory Practice) studies enable government, academic, and private-sector clients to manage research projects with unparalleled speed and regulatory compliance. Importantly, the CDC-licensed facilities ensure secure handling and quarantine of animals, fostering seamless transitions throughout research phases.
With its expertise in the Biopharma, Biotechnology, Health Care, and Pharmaceutical sectors, Alpha Genesis Inc. received its last investment, a $2.00M Debt Financing, on 01 February 2022. This strategic investment underscores confidence in their capabilities to propel critical biopharmaceutical research forward.
